Sign In
Get Clay Free →

Suggestions

    Bob Linke

    Chief Executive Officer at Osmol Therapeutics, Inc.

    Bob Linke is a seasoned Pharma/biopharmaceutical CEO known for his exceptional ability in building and leading emerging companies through various growth phases.

    Throughout his career, Bob has secured over $50 million in investor capital and $20 million in non-dilutive grant funding for company development while intricately developing robust patent portfolios to enhance company value.

    With a profound understanding of customer needs, Bob excels in focusing organizations and fostering an open management style that cultivates a cohesive, high-performing team.

    His extensive experience encompasses deep business insights and marketing/sales leadership within the multi-billion-dollar pharma industry, along with expertise in health informatics, device, and diagnostic markets.

    Bob Linke holds an MBA in General Management from Harvard Business School and a BA in Economics and Mathematics from Albion College.

    Throughout his career, Bob has held several significant leadership positions, including Chief Executive Officer at Osmol Therapeutics, Inc., Founder and President at RBL Life Science Advisors, LLC, and Executive Chairman of the Board of Directors at Embera NeuroTherapeutics, among others.

    Bob Linke
    Add to my network

    Location

    United States